The complement system and age-related macular degeneration.

The complement system and age-related macular degeneration.

PURPOSE: Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. There are increasing evidences to suggest the complement system may play a significant role on the pathogenesis of AMD. In this review, we summarise the current research in this area. METHODS: R...

Bibliografiset tiedot
Päätekijät:	Sivaprasad, S, Chong, N
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

Estimation of systemic complement C3 activity in age-related macular degeneration.
Tekijä: Sivaprasad, S, et al.
Julkaistu: (2007)

Systemic complement activation in age-related macular degeneration.
Tekijä: Hendrik P N Scholl, et al.
Julkaistu: (2008-07-01)

Systemic complement activation in age-related macular degeneration.
Tekijä: Scholl, H, et al.
Julkaistu: (2008)

Serum elastin-derived peptides in age-related macular degeneration.
Tekijä: Sivaprasad, S, et al.
Julkaistu: (2005)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration.
Tekijä: Hendrik P. N. Scholl, et al.
Julkaistu: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration.
Tekijä: Hendrik P. N. Scholl, et al.
Julkaistu: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Julkaistu: (2008-01-01)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Julkaistu: (2008-01-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
Tekijä: Niloofar Piri, et al.
Julkaistu: (2023-05-01)

“Complement-ary” Therapies for Age-Related Macular Degeneration
Tekijä: Jonathan B. Lin, MD, PhD, et al.
Julkaistu: (2022-06-01)

Pulsatile ocular blood flow in asymmetric age-related macular degeneration.
Tekijä: Sandhu, R, et al.
Julkaistu: (2007)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration
Tekijä: Jonathan B. Lin, MD, PhD, et al.
Julkaistu: (2022-06-01)

Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
Tekijä: Sivaprasad, S, et al.
Julkaistu: (2011)

The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application.
Tekijä: Charbel Issa, P, et al.
Julkaistu: (2011)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
Tekijä: Sobha Sivaprasad
Julkaistu: (2008-06-01)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
Tekijä: Prem N. Patel, et al.
Julkaistu: (2022-08-01)

Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.
Tekijä: Pearce, E, et al.
Julkaistu: (2011)

The Relationship between Complements and Age-Related Macular Degeneration and Its Pathogenesis
Tekijä: Liyuan Chu, et al.
Julkaistu: (2024-01-01)

Zinc supplementation inhibits complement activation in age-related macular degeneration.
Tekijä: Dzenita Smailhodzic, et al.
Julkaistu: (2014-01-01)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
Tekijä: Shruti Chandra, et al.
Julkaistu: (2023-02-01)

Interaction of complement factor h and fibulin3 in age-related macular degeneration.
Tekijä: M Keith Wyatt, et al.
Julkaistu: (2013-01-01)

Structural basis for complement factor H linked age-related macular degeneration.
Tekijä: Prosser, B, et al.
Julkaistu: (2007)

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
Tekijä: Shuqi Qin, et al.
Julkaistu: (2021-01-01)

Complement proteins and complement regulatory proteins are associated with age-related macular degeneration stage and treatment response
Tekijä: Alexander Kai Thomsen, et al.
Julkaistu: (2024-11-01)

Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
Tekijä: Chau, K, et al.
Julkaistu: (2007)

Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
Tekijä: Chau, K, et al.
Julkaistu: (2008)

Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration
Tekijä: Yutaka Kato, MD, et al.
Julkaistu: (2022-06-01)

Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype
Tekijä: Ralene Zi Hui Sim, MD, et al.
Julkaistu: (2022-12-01)

Radiotherapy for neovascular age-related macular degeneration.
Tekijä: Evans, JR, et al.
Julkaistu: (2010)

Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians vs Chinese.
Tekijä: Sivaprasad, S, et al.
Julkaistu: (2006)

Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
Tekijä: Anne M Lynch, et al.
Julkaistu: (2020-10-01)

The effect of complement factor B gene variation on age-related macular degeneration in Iranian patients
Tekijä: Nasrin Roshanipour, et al.
Julkaistu: (2019-09-01)

Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration
Tekijä: Matteo Stravalaci, et al.
Julkaistu: (2020-11-01)

Towards a structural basis for complement factor H linked age-related macular degeneration
Tekijä: Prosser, B, et al.
Julkaistu: (2007)

Bruch’s Membrane Compartmentalizes Complement Regulation in the Eye with Implications for Therapeutic Design in Age-Related Macular Degeneration
Tekijä: Simon J. Clark, et al.
Julkaistu: (2017-12-01)

Scotopic thresholds on dark-adapted chromatic perimetry in healthy aging and age-related macular degeneration
Tekijä: Manjot Kaur Grewal, et al.
Julkaistu: (2021-05-01)

Age-related macular degeneration
Tekijä: Querques G, et al.
Julkaistu: (2011-05-01)

Age-related macular degeneration
Tekijä: Wanjiku Mathenge
Julkaistu: (2014-12-01)

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
Tekijä: Adnan H. Khan, et al.
Julkaistu: (2023-06-01)

Systemic Dyslipidemia in Age-related Macular Degeneration
Tekijä: Brandon Li, et al.
Julkaistu: (2024-01-01)